Publication: Successful derivation of xeno-free mesenchymal stem cell lines from endometrium of infertile women
5
Issued Date
2016-12-01
Resource Type
ISSN
1642431X
Other identifier(s)
2-s2.0-84997173330
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Reproductive Biology. Vol.16, No.4 (2016), 261-268
Suggested Citation
Tatsanee Phermthai, Kittima Tungprasertpol, Suphakde Julavijitphong, Puttachart Pokathikorn, Sasiprapa Thongbopit, Suparat Wichitwiengrat Successful derivation of xeno-free mesenchymal stem cell lines from endometrium of infertile women. Reproductive Biology. Vol.16, No.4 (2016), 261-268. doi:10.1016/j.repbio.2016.10.002 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/43187
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Successful derivation of xeno-free mesenchymal stem cell lines from endometrium of infertile women
Other Contributor(s)
Abstract
© 2016 Society for Biology of Reproduction & the Institute of Animal Reproduction and Food Research of Polish Academy of Sciences in Olsztyn Transplantation of mesenchymal stem cells (MSC) can effectively repair endometrial deficiencies, including infertile patients with a problem of inadequate endometrium thickness. Although, MSC derived from different organ sources have a similarity of MSC specific characteristics, endometrial stem cells (EMSC) are temporally regulated throughout the menstrual cycle in a micro-environmental niche found only in endometrial tissue. Given the micro-environment niche, developing treatments for endometrial disorders with EMSC should be a top priority. To provide EMSC that afford safety for therapeutic usage, we have established a completely xeno-free EMSC line derivation protocol using human allogenic umbilical cord serum instead of animal derived reagents, and proved that it is feasible to generate xeno-free EMSC lines from infertile patient donors using these conditions. Our results demonstrate the successful derivation of xeno-free EMSC lines from 10 out of 10 infertile patients. The resultant xeno-free EMSC lines showed typical MSC morphology, phenotypic markers, differentiation capacity, telomere length and normal karyotypes. They showed superior proliferation capability, but lower expression of proto-oncogenes, to the lines generated under standard (animal derived reagents) culture. Biosafety of xeno-free EMSC lines also displayed in retention of immunosuppressive ability, epigenetic stability by imprinted genes expression, proto-oncogenes expression and no mutation of specific codon on p53 tumor suppressor gene. Taken together, these data indicate that our cells may be safe for clinical use. In conclusion, we have succeeded in establishing completely xeno-free EMSC lines and demonstrate for the first time that autogenic and xeno-free EMSC lines can be generated from infertile women.